Rochester Medical (ROCM), which specializes in catheters for treating incontinence in non-hospital settings, are higher in early trading after a Barron's article over the weekend said the stock could rally 50% in the next 18 months, citing an estimate from Somerest Capital Advisors. Rochester's recently announced plan to exit the Foley catheter business could help improve its margins, leading investors to reevaluate the company, the article contended. In morning trading, Rochester Medical shares rose over 18% to $14.04.
- Stocks & Offerings
- Investment & Company Information